• OPEN AN ACCOUNT
Indian Indices
Nifty
22,055.20 97.70
(0.44%)
Sensex
72,664.47 260.30
( 0.36%)
Bank Nifty
47,421.10 -66.80
( -0.14%)
Nifty IT
32,935.15 -270.70
( -0.82%)
Global Indices
Nasdaq
16,340.87 -5.39
(-0.03%)
Dow Jones
39,512.84 125.08
(0.32%)
Hang Seng
18,963.68 425.87
(2.30%)
Nikkei 225
38,229.11 155.13
(0.41%)
Forex
USD-INR
83.52 0.04
(0.05%)
EUR-INR
89.99 0.20
(0.22%)
GBP-INR
104.60 0.26
(0.25%)
JPY-INR
0.54 0.00
(-0.02%)

EQUITY - MARKET SCREENER

GKB Ophthalmics Ltd
Industry :  Personal Care - Indian
BSE Code
ISIN Demat
Book Value()
533212
INE265D01015
51.1440747
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GKB
0
53.43
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Divi's Laboratories plans capacity addition with investment of up to Rs 700 cr
Apr 25,2024
Divi's Laboratories is in the process of entering into a long-term supply agreement with a customer and is planning for capacity addition at its manufacturing facility with an estimated investment between Rs 650 crore to Rs 700 crore, to be funded from internal accruals. The proposed facility is expected to be operational around January, 2027.